Inflammatory bowel disease (IBD) is an immune-mediated chronic inflammation of the
intestine, which can present in the form of ulcerative colitis (UC) or as Crohn's disease (CD) …

Objectives: Crohn disease (CD) and ulcerative colitis (UC), known collectively as
inflammatory bowel diseases (IBDs), are chronic immunoinflammatory pathologies of …

Inflammatory bowel diseases (IBD) are systemic immune-mediated conditions with
predilection for the gastrointestinal tract and include Crohn's disease and ulcerative colitis …

Background The molecular aetiology of inflammatory bowel disease [IBD] and its two
subtypes, ulcerative colitis [UC] and Crohn's disease [CD], have been carefully investigated …

Inflammatory bowel diseases (IBD) are chronic, heterogeneous, and multifactorial intestinal
inflammatory disorders. Major challenges in IBD research include identification of major …

Objectives Resistin, a recently discovered adipokine, has been shown to be associated with
inflammatory conditions such as insulin resistance, obesity, atherosclerosis and rheumatoid …

Unambiguous diagnosis of the two main forms of inflammatory bowel diseases (IBD):
Ulcerative colitis (UC) and Crohn's disease (CD), represents a challenge in the early stages …

Recently, the field of proteomics has rapidly expanded in its application towards clinical
research with objectives ranging from elucidating disease pathogenesis to discovering …

Objective Genetic and immunological data indicate that inflammatory bowel disease (IBD)
are characterized by specific inflammatory protein profiles. However, the serum proteome of …

Background Faecal biomarkers have emerged as important tools in managing of
inflammatory bowel disease [IBD], which includes Crohn's disease [CD] and ulcerative colitis …